Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways

Bleomycin (BLM) is a chemotherapeutic agent which is associated with Idiopathic pulmonary fibrosis (IPF) due to its chronic administration. Hesperidin, a bioflavonoid has been reported to possess antioxidant, anti-inflammatory, wound healing, and antiapoptotic potential. To evaluate the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zheng, Kandhare, Amit D., Kandhare, Anwesha A., Bodhankar, Subhash L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785776/
https://www.ncbi.nlm.nih.gov/pubmed/31611754
http://dx.doi.org/10.17179/excli2019-1094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785776/
https://www.ncbi.nlm.nih.gov/pubmed/31611754
http://dx.doi.org/10.17179/excli2019-1094

Ejemplares similares